Alzamend Neuro, Inc. (ALZN)
NCM – Real Time Price. Currency in USD
1.45
-0.02 (-1.36%)
Market open: Aug 12, 2026, 11:58 AM EDT
1.46
-0.01 (-0.68%)
Previous after-hours: Aug 11, 2026, 5:59 PM EDT
Find any stock by ticker or company name

NCM – Real Time Price. Currency in USD
1.45
-0.02 (-1.36%)
Market open: Aug 12, 2026, 11:58 AM EDT
1.46
-0.01 (-0.68%)
Previous after-hours: Aug 11, 2026, 5:59 PM EDT
Revenue breakdown data has not been calculated yet.
No Data
There are no news for this stock.
Cash reserves $710.7K barely cover the upcoming debt maturities $0.0
Total current assets $1.8M exceed Total current liabilities $1.3M, highlighting excellent liquidity
Debt-to-equity ratio (0.0) is near the industry average, reflecting balanced leverage
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$2.8M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 1.31 | 6.05 | 7.0 | |
| Quick ratio | 1.31 | 5.63 | 7.0 | |
| Debt to Equity | 0.00 | 0.30 | 10 | |
| Debt to Assets | 0.00 | 1.04 | 10 | |
| Interest coverage | N/A | -16.91 | 1.0 | |
| Weighted average score | 7.0 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | -23K | -51K | -51K | -111K | -111K |
| Operating Income | -15M | -10M | -4M | -9M | -9M |
| Net Income | -15M | -10M | -5M | -9M | -9M |
| EBITDA | -15M | -10M | -4M | -9M | -9M |
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Gross margin % | N/A | -11.73 | 1.0 | |
| Operating margin % | N/A | -24.60 | 1.0 | |
| Net margin % | N/A | -172.20 | 1.0 | |
| EBITDA margin % | N/A | -201.27 | 1.0 | |
| Cash flow margin % | N/A | -156.39 | 1.0 | |
| Weighted average score | 1.0 | |||
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | 47.66 | 5.5 |
| Next quarter | N/A | -120 | 1.0 |
| Current year | N/A | 75.82 | 5.5 |
| Next year | N/A | -0.78 | 1.0 |
| Weighted average score | 3.3 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 999 | -30.5 | -93.32 | -61.1 | 3.3 |
| Y/Y | 999 | -151.86 | 66.08 | -211.25 | 5.5 |
| 3y average | 999 | -2.17 | 63.3 | 2.2 | 6.0 |
| 5y average | 999 | -34.36 | 4.87 | -34.78 | 4.0 |
| Weighted average score | 4.7 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |